uracil has been researched along with Myelodysplastic Syndromes in 2 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.
Excerpt | Relevance | Reference |
---|---|---|
"Acute myeloid leukemia was finally diagnosed in October 1998, and chromosomal analysis disclosed inv(3) in addition to -5 and -7." | 1.31 | [Essential thrombocythemia in transformation from myelodysplastic syndrome to acute myeloid leukemia with inv(3) after treatment for gastric cancer]. ( Aoki, K; Chiba, S; Hirai, H; Honda, H; Horikoshi, M; Itikawa, M; Kurokawa, M; Machida, U; Masuda, S; Mitani, K; Ogawa, S; Seo, S; Sunaga, S; Yazaki, Y, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Horikoshi, M | 1 |
Machida, U | 1 |
Itikawa, M | 1 |
Seo, S | 1 |
Masuda, S | 1 |
Kurokawa, M | 1 |
Ogawa, S | 1 |
Sunaga, S | 1 |
Honda, H | 1 |
Aoki, K | 1 |
Chiba, S | 1 |
Mitani, K | 1 |
Hirai, H | 1 |
Yazaki, Y | 1 |
Abe, M | 1 |
Tanaka, Y | 1 |
Shinohara, M | 1 |
Kosaka, M | 1 |
Matsumoto, T | 1 |
2 other studies available for uracil and Myelodysplastic Syndromes
Article | Year |
---|---|
[Essential thrombocythemia in transformation from myelodysplastic syndrome to acute myeloid leukemia with inv(3) after treatment for gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chromosome Inversion; Chromosomes, Human, Pair | 2000 |
Myelodysplastic syndrome/acute myelogenous leukaemia related to adjuvant chemotherapy with oral pyrimidine anti-metabolites.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Drug Administration Schedu | 2000 |